Relationship of the main indicators of systemic COVID-associated endotheliopathy with the morphofunctional state and hemodynamics of the retina and chorioid in the acute period of the disease

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

BACKGROUND: Nonspecific angio- and retinopathy is one of the clinical manifestations of a new coronavirus infection. The frequency of occurrence of these changes in people with severe COVID-19 does not exceed 55%. The causes, course and consequences of these microcirculatory disorders of the retina are currently not well understood.

AIM: To study and compare of retinal morphometric parameters and systemic endothelial dysfunction markers, as well as the main clinical and laboratory parameters in patients with moderate and severe coronavirus infection during convalescence.

MATERIALS AND METHODS: The study involved 44 patients (86 eyes) who had COVID-19 during the previous 3 months, who were divided into 2 groups: with moderate and severe disease. The control group consisted of 18 healthy volunteers (36 eyes). All patients underwent a standard ophthalmological examination and optical coherence tomography, which included an assessment of the choroidal thickness (CT) and measurement of the mean diameter of the peripapillary arteries (MAD) and veins (MVD). During hospitalization, all patients underwent a laboratory study of venous blood parameters, as well as an assessment of the microcirculation of the sublingual plexus by examining the density of the endothelial glycocalyx (PBR) using the GlycoCheck.

RESULTS: In patients who underwent COVID-19, there was a significant increase in CT relative to the control group, amounting to 308, 344 and 392 μm, respectively. The most pronounced difference was observed between MVD in patients with severe infection and the control group (119.1 μm vs. 99.2 μm). In patients with moderate and severe COVID-19, MAD and MVD were positively correlated with TC, with r = 0.389 and r = 0.584, respectively. MVD also correlated with the level of leukocytes (r = 0.504), the ESR value (r = 0.656). Correlations between MVD and data characterizing the state of the glycocalyx in the sublingual vascular plexus were revealed: the filling of small capillaries with erythrocytes (r = –0.587), as well as the marginal perfusion value in large capillaries 20–25 μm (r = 0.479) and PBR (r = 0.479). Only significant differences and correlations are shown (p < 0.005).

CONCLUSIONS: In patients who underwent moderate and severe COVID-19 during the convalescence period (up to 30 days), an increase in the diameter of peripapillary vessels and TC is observed, proportional to the severity of COVID-19, laboratory markers of systemic inflammation and hypercoagulation (the number of leukocytes, the ESR value, D-dimer and prothrombin), which indicates the inflammatory nature of the changes. The severity of postcovid retinal microangiopathy correlates with indicators detecting a decreasing of the endothelial glycocalyx thickness in the sublingual capillary plexus, which indirectly indicates a connection with systemic endotheliopathy.

About the authors

Vadim A. Turgel

Academician I.P. Pavlov First St. Petersburg State Medical University

Author for correspondence.
Email: zanoza194@gmail.com
ORCID iD: 0000-0003-3049-1974

Postgraduate Student, Prof. Yu.S. Astakhov Department of Ophthalmology with Clinic

Russian Federation, Saint Petersburg

Svetlana N. Tultseva

Academician I.P. Pavlov First St. Petersburg State Medical University

Email: tultceva@yandex.ru
ORCID iD: 0000-0002-9423-6772
SPIN-code: 3911-0704

MD, Dr. Sci. (Med.), Professor. Prof. Yu.S. Astakhov Department of Ophthalmology with Clinic

Russian Federation, Saint Petersburg

References

  1. de Miguel Buckley R, Díaz-Menéndez M, García-Rodríguez J, Arribas JR. Seasonal coronavirus pneumonia after SARS-CoV-2 infection and vaccination: new frenemies? J Infect Dis. 2022;225(4): 741–743. doi: 10.1093/infdis/jiab421
  2. Yamaoka-Tojo M. Vascular endothelial glycocalyx damage in COVID-19. Int J Mol Sci. 2020;21(24):9712. doi: 10.3390/ijms21249712
  3. Mahdjoubi A, Bousnina Y, Barrande G, et al. Features of cotton wool spots in diabetic retinopathy: a spectral-domain optical coherence tomography angiography study. Int Ophthalmol. 2020;40: 1625–1640. doi: 10.1007/s10792-020-01330-7
  4. COVID-19 and vascular disease. EBioMedicine. 2020;58:102966. doi: 10.1016/j.ebiom.2020.102966
  5. Bansal R, Markan A, Gautam N, et al. Retinal involvement in COVID-19: results from a prospective retina screening program in the acute and convalescent phase. Front Med. 2021;8:681942. doi: 10.3389/FMED.2021.681942
  6. Illarionova AR, Potapova OM, Kosareva OA, Kuznetsova YuR. Frequency of retinal changes in patients with COVID-19: an observational study. Sechenov Medical Journal. 2020;11(2):40–49. (In Russ.) doi: 10.47093/2218-7332.2020.11.2.40-49
  7. Lani-Louzada R, do Val Farreira Ramos C, Cordeiro RM, Sadun AA. Retinal changes in COVID-19 hospitalized cases. PLoS ONE. 2020;15(12): e0243346. doi: 10.1371/journal.pone.0243346
  8. Invernizzi A, Torre A, Parrulli S, et al. Retinal findings in patients with COVID-19: Results from the SERPICO-19 study. EClinicalMedicine. 2020;27:100550. doi: 10.1016/j.eclinm.2020.100550
  9. Jidigam VK, Singh R, Batoki JC, et al. Histopathological assessments reveal retinal vascular changes, inflammation and gliosis in patients with lethal COVID-19. Graefes Arch Clin Exp Ophthalmol. 2021;2(5). doi: 10.1101/2021.02.25.21251531
  10. Landecho MF, Yuste JR, Gándara E, et al. COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease? J Intern Med. 2020;289(1):116–120. doi: 10.1111/joim.13156
  11. Turgel VА, Tultseva SN. Study of the retina and optic nerve microvascular bed using optical coherence tomography-angiography in post-COVID-19 patients. Regional blood circulation and microcirculation. 2021;20(4):21–32. (In Russ.) doi: 10.24884/1682-6655-2021-20-4-21-32
  12. Huertas A, Montani D, Savale L, et al. Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)? Eur Respir J. 2020;56:2001634. doi: 10.1183/13993003.01634-2020
  13. Teuwen L-A, Geldhof V, Pasut A, Carmeliet P. COVID-19: the vasculature unleashed. Nat Rev Immunol. 2020;21:389–391. doi: 10.1038/s41577-020-0343-0
  14. Harrison DG, Cai H. Endothelial control of vasomotion and nitric oxide production. Cardiol Clin. 2003;21(3):289–302. doi: 10.1016/s0733-8651(03)00073-0
  15. Gavriilaki E, Brodsky RA. Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily. Br J Haematol. 2020;189(6):227–230. doi: 10.1111/bjh.16783
  16. Petrishchev NN, Khalepo OV, Vavilenkova YA, Vlasov TD. COVID-19 and vascular disorders (literature review). Regional blood circulation and microcirculation. 2020;19(3):90–98. (In Russ.) doi: 10.24884/1682-6655-2020-19-3-90-98
  17. Pober JS, Sessa WC. Evolving functions of endothelial cells in inflammation. Nat Rev Immunol. 2007;7:803–815. doi: 10.1038/nri2171
  18. Aşıkgarip N, Temel E, Hızmalı L, et al. Retinal vessel diameter changes in COVID-19 infected patients. Ocul Immunol Inflamm. 2021;29(4):645–651. doi: 10.1080/09273948.2020.1853783
  19. Gündoğan M, Vural E, Bayram N, et al. Change in retinal vessel diameter and choroidal thickness in patients with severe COVID-19: Change in retinal parameters in patients with severe COVID-19. Photodiagnosis Photodyn Ther. 2021;37:102674. doi: 10.1016/j.pdpdt.2021.102674
  20. Cennamo G, Reibaldi M, Montorio D, et al. Optical coherence tomography angiography features in post-COVID-19 pneumonia patients: a pilot study. Am J Ophthalmol. 2021;227:182–190. doi: 10.1016/j.ajo.2021.03.015
  21. Guemes-Villahoz N, Burgos-Blasco B, Vidal-Villegas B, et al. Reduced macular vessel density in COVID-19 patients with and without associated thrombotic events using optical coherence tomography angiography. Graefes Arch Clin Exp Ophthalmol. 2021;259(8): 2243–2249. doi: 10.1007/s00417-021-05186-0
  22. González-Zamora J, Bilbao-Malavé V, Gándara E, et al. Retinal microvascular impairment in COVID-19 bilateral pneumonia assessed by optical coherence tomography angiography. Biomedicines. 2021;9(3):247. doi: 10.3390/biomedicines9030247
  23. Oren B, Aksoy Aydemır G, Aydemır E, et al. Quantitative assessment of retinal changes in COVID-19 patients. Clin Exp Optom. 2021;104(6):717–722. doi: 10.1080/08164622.2021.1916389
  24. Dag Seker E, Erbahceci Timur IE. COVID-19: more than a respiratory virus, an optical coherence tomography study. Int Ophthalmol. 2021;41(11):3815–3824. doi: 10.1007/s10792-021-01952-5
  25. Hernandez M, González-Zamora J, Recalde S, et al. Evaluation of macular retinal vessels and histological changes in two cases of COVID-19. Biomedicines. 2021;9(11):1546. doi: 10.3390/biomedicines9111546

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Scheme for measuring the diameter of vessels and their lumens in the inferotemporal quadrant of the right eye using the built-in tomograph tools on the HRA image

Download (246KB)
3. Fig. 2. Examination of the glycocalyx of mucosal capillaries in the sublingual area using the GlycoCheck system: a — general view of the patient; b — random frame from the camera of the GlycoCheck system, magnification ×325

Download (123KB)
4. Fig. 3. The thickness of the choroid in the subfoveolar region in patients of different groups

Download (97KB)
5. Fig. 4. Average values of the peripapillary arteries and veins thickness in the examined groups

Download (125KB)
6. Fig. 5. Distribution diagram of the average thickness of the choroid and MVD in groups 1 and 2

Download (67KB)
7. Fig. 6. Distribution of MVD and white blood cell count in patients with COVID-19

Download (79KB)

Copyright (c) 2022 Turgel V.A., Tultseva S.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies